Project Koru is a nonprofit organization that seeks to enrich the lives of young adult cancer survivors through outdoor and adventure-based community experiences. At the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Beth Peck, the organization's Executive Director, sat down with Oncology Data Advisor to talk about its mission and the excitement of sharing the ASCO experience with others who have a common goal.

This podcast episode was recorded live at the 2022 ASCO Annual Meeting in Chicago by Oncology Data Advisor and ConveyMed. 

At the recent American Society of Clinical Oncology (ASCO) Annual Meeting, Megan-Claire Chase, breast cancer survivor and Breast Cancer Program Director at SHARE Cancer Support, sat down with Oncology Data Advisor to talk about her diagnosis, treatment, and survivorship journey, as well as her advocacy work to empower people living with cancer.

This podcast episode was recorded live at the 2022 ASCO Annual Meeting in Chicago by Oncology Data Advisor and ConveyMed. 

At the recent 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Jason Westin, Director of Lymphoma Clinical Research at MD Anderson Cancer Center, presented the primary overall survival analysis of the phase 3 ZUMA-7 trial investigating axicabtagene ciloleucel for relapsed/refractory large B-cell lymphomas. In this interview, he shares more with Oncology Data Advisor regarding the efficacy, safety, and future directions of this promising agent. 

At the American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Navdeep Dehar, a Medical Oncology Fellow at Queen's University in Ontario, sat down with Oncology Data Advisor to share the excitement of her first ASCO experience and the valuable research being presented there.

This podcast episode was recorded live at the 2022 ASCO Annual Meeting in Chicago by Oncology Data Advisor and ConveyMed. 

At the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Dr. David Penberthy, President of the Association of Community Cancer Centers (ACCC), sat down with Oncology Data Advisor to discuss his President's Theme for ACCC this year, which involves utilizing technology to improve the delivery of cancer care in order to optimize patient experiences.

This podcast episode was recorded live at the 2022 ASCO Annual Meeting in Chicago by Oncology Data Advisor and ConveyMed. 

At the recent American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Dr. Jason Mouabbi of MD Anderson Cancer Center presented a poster focused on survival outcomes of patients with invasive lobular carcinoma treated with endocrine therapy plus a CDK4/6 inhibitor, mammalian target of rapamycin (mTOR) inhibitor, or a PI3K inhibitor, in comparison to those with metastatic hormone receptor–positive, human epidermal growth factor receptor 2 (HER2)–negative invasive ductal carcinoma. Afterwards, he sat down with Oncology Data Advisor to explain the implication of the study's results and the need for additional research in the field of lobular breast cancer to improve patient outcomes. 

This podcast episode was recorded live at the 2022 ASCO Annual Meeting in Chicago by Oncology Data Advisor and ConveyMed.  

At the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Danet Peterson sat down with Oncology Data Advisor to talk about her work with A Cure in Sight, a nonprofit organization which seeks to support patients with ocular melanoma throughout the diagnosis, treatment, and survivorship journey.

This podcast episode was recorded live at the 2022 ASCO Annual Meeting in Chicago by Oncology Data Advisor and ConveyMed. 

During the recent American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Dr. Urvi Shah from Memorial Sloan Kettering Cancer Center sat down with Oncology Data Advisor to share her perspectives on the exciting research that was presented in the poster discussion session she chaired on novel therapies for multiple myeloma. In addition, Dr. Shah explains more about her work to impact patients' quality of life and outcomes through nutritional interventions.

This podcast episode was recorded live at the 2022 ASCO Annual Meeting in Chicago by Oncology Data Advisor and ConveyMed. 

At the recent American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, Dr. Ash Alpert, a postdoctoral fellow in health services research at Brown University, presented two posters regarding the associations between violence and cancer risk factors for transgender and cisgender people. In this follow-up interview with Oncology Data Advisor, Dr. Alpert delves further into the implications of these two studies' results and shares how their ongoing research in this field seeks to improve the care of transgender people in the health care setting.  

Large population next-generation sequencing of tumors for mutations in certain key oncogenes is an important avenue of research for discovering genes that can predict survival or even support the use of targeted therapies for certain patients. At the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Dr. Sam Kareff, MD, MPH, presented a poster about his research about how mutations in the oncogene HRAS affect prognosis and response to therapy in breast cancer. He determined that certain types of HRAS mutation are associated with poor survival and that patients with these mutations may benefit from targeted therapies.

This podcast episode was recorded live at the 2022 ASCO Annual Meeting in Chicago by Oncology Data Advisor and ConveyMed. 

At the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Ms. Stephanie Van Winkle, Executive Director of the Oncology State Societies at the Association for Community Cancer Centers (ACCC), sat down with Oncology Data Advisor to discuss how the oncology state societies and the Association for Community Cancer Centers empower legislative advocacy work.  

This podcast episode was recorded live at the 2022 ASCO Annual Meeting in Chicago by Oncology Data Advisor and ConveyMed.

At the recent American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Aamir Ehsan, MD, Medical Director at CorePath Laboratories, spoke with Oncology Data Advisor to delve into the topic of personalized and precise diagnosis of cancer by pathology, a topic that he is passionate about other pathologists and oncologists understanding.

This podcast episode was recorded live at the 2022 ASCO Annual Meeting in Chicago, by Oncology Data Advisor and ConveyMed.